We are live on ! Find out more
AEON icon

AEON Biopharma
AEON

21 hedge funds and large institutions have $1.1M invested in AEON Biopharma in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

88% more capital invested

Capital invested by funds: $586K → $1.1M (+$518K)

17% more funds holding

Funds holding: 18 → 21 (+3)

0.47% more ownership

Funds ownership: 11.24% → 11.72% (+0.47%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$76K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.3K
3
SG
StoneX Group
New York
+$13.5K
4
XT
XTX Topco
Cayman Islands
+$12.5K
5
Jane Street
Jane Street
New York
+$8.03K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$34K
2
UBS Group
UBS Group
Switzerland
-$23.4K
3
Citigroup
Citigroup
New York
-$207
4
BlackRock
BlackRock
New York
-$16
5
Bank of America
Bank of America
North Carolina
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
DIG
1
Dauntless Investment Group
New Hampshire
$910K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$79.7K +$76K +98,568 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$38.1K +$20.3K +26,378 +127%
BOCH
4
Blue Owl Capital Holdings
New York
$34.2K – – –
SG
5
StoneX Group
New York
$14.2K +$13.5K +17,578 New
XT
6
XTX Topco
Cayman Islands
$13.1K +$12.5K +16,162 New
Jane Street
7
Jane Street
New York
$8.43K +$8.03K +10,420 New
BlackRock
8
BlackRock
New York
$2.29K -$16 -21 -0.7%
Bank of America
9
Bank of America
North Carolina
$1.92K -$7 -9 -0.4%
UBS Group
10
UBS Group
Switzerland
$964 -$23.4K -30,408 -96%
DCM
11
Dupont Capital Management
Delaware
$137 – – –
Morgan Stanley
12
Morgan Stanley
New York
$121 – – –
SS
13
SBI Securities
Japan
$86 – – –
SPIA
14
Steward Partners Investment Advisory
New York
$81 – – –
GIA
15
GHP Investment Advisors
Colorado
$77 +$55 +71 +296%
Wells Fargo
16
Wells Fargo
California
$73 – – –
WWM
17
Wolff Wiese Magana
California
$55 – – –
MCM
18
MAI Capital Management
Ohio
$47 – – –
CIBC Private Wealth Group
19
CIBC Private Wealth Group
Georgia
$27 – – –
Barclays
20
Barclays
United Kingdom
$17 +$16 +21 New
DB
21
Danske Bank
Denmark
$1 – – –
HF
22
HRT Financial
New York
– -$34K -45,258 Closed
Citigroup
23
Citigroup
New York
– -$207 -272 Closed

AEON Hedge Fund Activity: Q3 2025 in Review

21 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma (AEON) for Q3 2025, worth a combined $1.1M — up 88% from $586K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new AEON positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $76K. The largest seller was HRT Financial, exiting entirely with an estimated $34K sold.

  • 21 institutional investors held AEON Biopharma (AEON) as of Q3 2025, up from 18 in Q2 2025.
  • Funds reported $1.1M of AEON Biopharma stock for Q3 2025, up 88% quarter-over-quarter.
  • 5 funds opened new AEON Biopharma positions in Q3 2025 and 2 closed out, a net change of +3 holders.
  • The largest AEON Biopharma buyer in Q3 2025 was Vanguard Group, an estimated $76K added.
  • The largest AEON Biopharma seller in Q3 2025 was HRT Financial, an estimated $34K sold.

Based on aggregated 13F filings for Q3 2025.